Suchergebnisse - %22Pandemic%22

PubPharm (6)

1

Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors

enthalten in: Journal of virology | 2022

von Jiao, Z. | Yan, Y. | Chen, Y. | +8

2

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism

enthalten in: International journal of molecular sciences | 2022

von Ho, C. | Yu, J. | Wang, Y. | +8

3

Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Sultan, A. | Ali, R. | Ishrat, R. | +1

4

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

enthalten in: Molecular medicine (Cambridge, Mass.) | 2021

von Duarte, R. | Copertino, D. | Iñiguez, L. | +7

5

Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

enthalten in: Viruses | 2021

von Huang, S. | Chen, Y. | Chang, W. | +8

6

Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro) Inhibitors from Melissa officinalis

enthalten in: Current drug discovery technologies | 2021

von Elekofehinti, O. | Iwaloye, O. | Famusiwa, C. | +2

1
[1]